10 Best Performing Biotech ETFs in 2024 - Insider Monkey
In this article, we discuss the 10 best performing biotech ETFs in 2024.
Source: insidermonkey.com
Tema Cardiovascular News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tema Cardiovascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tema Cardiovascular Today - Breaking & Trending Today
Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming.
Source: cnbc.com
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market - Tema Cardiovascular and Metabolic ETF (NASDAQ:HRTS), Altimmune (NASDAQ:ALT)
Weight-loss drugs such as Ozempic and Mounjaro are the leading blockbusters for a new epidemic
Source: benzinga.com
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!
A niche issuer launches a biotech ETF whose core holdings include companies benefiting from the GLP-1 weight-loss drug craze. The Tema Cardiovascular and Metabolic ETF tracks companies involved in...
Source: marketscreener.com
Baystreet.ca - Don't Know Which Weight-Loss Stock Will Be the Biggest Winner? Invest in This ETF Instead
There’s a lot of excitement in the weight-loss industry these days. Between Ozempic, Wegovy, Mounjaro, and now Zepbound, investors have been hearing a lot of different names in the industry of late. And there are still more treatments that will ...
Source: baystreet.ca